Stuart McGurnaghan

16PUBLICATIONS
72CO-AUTHORS
Central nervous systemGene expression (incl. microarray and other genome-wide approaches)Epigenetics (incl. genome methylation and epigenomics)Epidemiological modellingMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jun 11, 2026
Long-term Effect of C-Peptide Level on Clinical Outcomes in the Scottish Type 1 Bioresource Cohort.

|Aug 11, 2025
Genome-Wide Aggregated Trans Effects Analysis for Circulating Proteins Indicates a Key Role of Immune Checkpoints in Type 1 Diabetes.

Xuan Zhou, Andrii Iakovliev, Stuart McGurnaghan

|Nov 18, 2024
Genetics of C-Peptide and Age at Diagnosis in Type 1 Diabetes.

Delnaz Roshandel, Athina Spiliopoulou, Stuart J McGurnaghan

|Jul 22, 2024
Estimating risk of consequences following hypoglycaemia exposure using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trials.

Joseph Mellor, Dmitry Kuznetsov, Simon Heller

|Jun 18, 2024
Impact of COVID-19 and Non-COVID-19 Hospitalized Pneumonia on Longer-Term Cardiovascular Mortality in People With Type 2 Diabetes: A Nationwide Prospective Cohort Study From Scotland.

Stuart J McGurnaghan, Paul M McKeigue, Luke A K Blackbourn

|May 25, 2024
Risk factors and prediction of hypoglycaemia using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trials.

Joseph Mellor, Dmitry Kuznetsov, Simon Heller

Pageof 3

Frequent Collaborators

14 joint publications

Paul M McKeigue

14 joint publications

Helen M Colhoun

11 joint publications

Luke Blackbourn

6 joint publications

Joseph Mellor